United States: Last week, a grave communiqué emerged from the Centers for Disease Control and Prevention (CDC), drawing urgent focus to the surge of dengue fever — a tormenting, sometimes lethal virus spread by mosquitoes, largely endemic to humid tropical and subtropical locales. According to the CDC’s account, roughly 3,500 American voyagers returned home in 2024 carrying the viral hitchhiker — an 84 percent escalation over the previous year. “This upward trajectory is forecast to persist,” the agency warned, identifying Florida, California, and New York as epicenters of impending proliferation.
Simultaneously, across the Atlantic, the United Kingdom Health Security Agency sounded a parallel alarm. Their figures indicated 900 travel-associated dengue diagnoses in 2024 — nearly 300 more than the prior annum. While both agencies delivered numerical snapshots of symptoms and rising cases, the UK’s advisory pierced deeper — naming the culprits: a heating planet, swelling tides, and intensifying storms. These environmental upheavals are scripting dengue’s meteoric ascent, according to the reports by grist.org.
Historically, the CDC has not shied away from acknowledging climate change’s role in disease transmission. However, since Donald Trump’s return to the presidency, the federal stance has changed course. Scientific lexicons such as “climate change” and “equity” have vanished from government websites. The agencies once tasked with decoding environmental threats have been systematically gutted — their data tools dismantled, their research pipelines throttled.
In a chilling turn, ProPublica revealed that the National Institutes of Health (NIH) — the globe’s most prolific patron of biomedical inquiry — will no longer extend funding for climate-linked health investigations. The future of existing grants now hangs in limbo. Days later, Health and Human Services Secretary Robert F. Kennedy Jr. declared a colossal retrenchment — 10,000 federal roles, including many at the CDC, are set to vanish. Ironically, this is the very agency born in 1946 to combat malaria, another mosquito-borne plague.
These sweeping edicts will hobble America’s readiness — and that of international collaborators reliant on NIH’s fiscal support — at the exact juncture when dengue is surging under climate duress. Stripping skilled personnel and dismantling institutions during a viral crescendo foretells grim outcomes as disease vectors like mosquitoes, fungi, and ticks migrate into previously untouched regions, as per grist.org.
“The pressure from vector-borne illness is swelling — and only trending upward,” remarked Scott O’Neill, founder of the World Mosquito Program, a global nonprofit combating mosquito-borne illness through biologically altered vectors. Brazil, long entrenched in dengue warfare, marked a record-shattering 10 million infections in 2024 — an immense spike from the 1.7 million in 2023.
The dengue virus is primarily ferried by Aedes aegypti and Aedes albopictus mosquitoes — creatures that thrive in climates increasingly sculpted by fossil-fueled warming. Although many infected experience no symptoms, nearly a quarter suffer fever, migraine, and debilitating joint agony. In rare cases, it morphs into severe illness — requiring hospitalization and sometimes ending in death.
The burden of lethal infections is a grim shadow of the total case count. For example, 2023 saw 6 million global infections and 6,000 fatalities. In 2024, those numbers doubled — 13 million afflicted and over 8,000 deceased.
There is no cure for dengue. Those in affluent countries often weather the illness with more support than those in under-resourced regions, where strained hospitals crumble under wave after wave of patients. Two vaccines exist — but both carry caveats concerning how long immunity lasts and their efficacy across demographics.
Between 2021 and the present, the NIH nurtured a bloom of climate-health scholarship — investing in projects probing how heat redraws mosquito maps, identifying outbreak triggers, and designing community resilience strategies post-flood or heatwave. These inquiries spanned from the American Southeast to nations like Brazil and Peru, where dengue is nearly perennial. NIH-backed researchers were edging toward breakthroughs, from smarter vaccines to genetically engineered mosquitoes incapable of transmitting the virus, according to the reports by grist.org.
“Viruses defy borders,” said one American entomologist and NIH grantee, who requested anonymity out of fear of retribution under the current administration. “If we abandon this line of inquiry, we surrender our future readiness.”
Dengue isn’t just a souvenir from overseas trips anymore — it’s sprouting roots within US borders. In early 2024, Puerto Rico rang the alarm, declaring a public health emergency amid a tidal wave of infections that crossed the epidemic threshold. Over half of those infected required hospitalization. A staggering 113 percent spike in cases compared to the same timeframe in 2024 has already been reported. California logged its first locally transmitted case last year. Florida noted 91 such infections in 2023 alone.
“This virus is now finding purchase in American zip codes that never before bore its sting,” noted Dr. Renzo Guinto, head of the Planetary Health Initiative at Duke-NUS in Singapore. “Yet without funding, without infrastructure, without partnerships, how can the US remain part of a global defense?”
Alternate funding sources — think Gates Foundation or the Wellcome Trust — do exist. However, their allocations pale next to the USD 40 million NIH annually devoted to climate-health fusion research pre-Trump. Now, scientists will be left clawing for diminishing grants — breeding scarcity and stifling discovery. “We’ll see a steep drop in innovation,” the same entomologist predicted. “And the American public will be worse off for it.”
As dengue fans out across its familiar tropics and inches deeper into temperate nations unaccustomed to its presence, the global need for smarter, faster, broader defense tools becomes unmistakable. But while the world girds itself, the US appears to be disarming, as per reports by grist.org.
“We’re standing at the crossroads,” said O’Neill. “This is the moment to galvanize invention and mobilize science — not muzzle it under ideology.”